Par Drugs and ChemicalsNSE:PAR +2.45%76 Days Payable is 83.93 as of Mar. 2026, which is 33% above its 10-year median of 63.30. GuruFocus rates NSE:PAR with a GF Score™ of 76/100 and a GF Value™ of ₹207.75 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 922 Drug Manufacturers companies, Par Drugs and Chemicals ranks worse than 56.62% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Par Drugs and Chemicals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's Days Payable distribution charts can be found below:
* The bar in red indicates where Par Drugs and Chemicals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Par Drugs and Chemicals's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Par Drugs and Chemicals (NSE:PAR) has a Days Payable of 83.93 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Par Drugs and Chemicals and its competitors. This is 33% above median its historical median of 63.30. Over the past decade, Par Drugs and Chemicals' Days Payable has ranged from 41.68 to 80.90. According to the industry distribution chart, Par Drugs and Chemicals ranks #522 out of 922 companies in the Drug Manufacturers industry, placing it in the top 56.6%.
Is Par Drugs and Chemicals' Days Payable too high?
Par Drugs and Chemicals' current Days Payable of 83.93 is 33% above median its 10-year median of 63.30. Over the past 10 years, this metric has ranged from a low of 41.68 to a high of 80.90. The Drug Manufacturers industry median Days Payable is 90.84. Par Drugs and Chemicals' value of 83.93 is 7.6% below this industry median. Based on the distribution chart, Par Drugs and Chemicals ranks #522 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Par Drugs and Chemicals has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Par Drugs and Chemicals' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Par Drugs and Chemicals ranks #522 out of 922 companies for Days Payable. This places Par Drugs and Chemicals in the lower half of its industry. The industry median Days Payable is 90.84. Par Drugs and Chemicals' value of 83.93 is 7.6% below this benchmark. Historically, Par Drugs and Chemicals' own Days Payable has ranged from 41.68 to 80.90 over the past decade. While the company's 10-year median is 63.30 vs. the industry median of 90.84, Par Drugs and Chemicals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Par Drugs and Chemicals's current Days Payable of 83.93 is 7.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Par Drugs and Chemicals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Par Drugs and Chemicals's current Days Payable is 83.93, which is 33% above median its own 10-year median of 63.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Par Drugs and Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Par Drugs and Chemicals (NSE:PAR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹207.75, compared to a current price of ₹90.70 — trading 56.3% below its estimated fair value. The current Days Payable is 83.93, which is 33% above median its 10-year median of 63.30 and 7.6% below the Drug Manufacturers industry median of 90.84. Par Drugs and Chemicals' overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Par Drugs and Chemicals (NSE:PAR), the current Days Payable is 83.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Par Drugs and Chemicals (NSE:PAR) Overvalued in 2026?
Based on GuruFocus' analysis, Par Drugs and Chemicals stock appears to be undervalued.
The current stock price of ₹90.70 is trading 56.3% below its estimated GF Value™ of ₹207.75.
GuruFocus considers Par Drugs and Chemicals to be Significantly Undervalued.
Key valuation signals for NSE:PAR:
Days Payable: 83.93 (33% above median its 10-year median of 63.30)
GF Value™: ₹207.75 vs. price of ₹90.70 (56.3% below fair value)
Industry Position: 7.6% below the Drug Manufacturers median (#522 of 922)
No single metric tells the full story. See the NSE:PAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Par Drugs and Chemicals Ltd manufactures active Pharmaceutical Ingredients (APIs) and fine chemicals, serving domestic and international markets. Specializing in essential magnesium-based compounds and other specialty chemicals such as Magnesium Hydroxide, Magnesium Trisilicate, Magnesium Carbonate, various grades of Magnesium Oxide, Dried Aluminum Hydroxide Gel, and Sucralfate USP, the Company produces high-quality bulk drugs used in the formulation of finished pharmaceutical products like tablets, capsules, and liquids. Committed to maintaining stringent quality standards and utilizing manufacturing processes, the Company plays a vital role in supplying reliable ingredients that ensure the safety, efficacy, and stability of pharmaceutical formulations internationally.
76GF Score
Get the complete analysis for NSE:PAR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PAR has been successfully added to your 
